Atlas Trials

Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases

Clinical trial NCT01934790 · COMPLETED

Trial details

NCT number
NCT01934790
Sponsor
Bayer
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prostatic Neoplasms
Start date
2013-12-22
Primary completion
2015-06-04
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.